The natural history of type B Niemann-Pick disease: results from a 10-year longitudinal study
- PMID: 15545621
- DOI: 10.1542/peds.2004-0887
The natural history of type B Niemann-Pick disease: results from a 10-year longitudinal study
Abstract
Objectives: Type B Niemann-Pick disease (NPD-B) caused by acid sphingomyelinase deficiency is a rare, autosomal recessive, lysosomal storage disorder with a broad range of disease severity. The objectives of this study were to document the natural history of the disease in a large, clinically heterogeneous patient population that was followed for a period of 10 years and to determine how genotype influences phenotype.
Methods: Twenty-nine patients with NPD-B had serial evaluations at least 9 months apart. Organ volumes, hematologic indices, lipid concentrations, pulmonary function, and hepatic activity were studied, and individual phenotypic severity was compared with genotype.
Results: All patients with intact spleens had splenomegaly (mean value: 12.7 multiples of normal [MN]; range: 4.5-27.3 MN), and all but 1 had hepatomegaly (mean volume: 1.91 MN; range: 0.93-3.21 MN). At initial visit, 39% had thrombocytopenia and 3% had leukopenia. At final visit, the percentages increased to 54% and 34%, respectively. Mean annual decreases in platelet count and leukocyte count were 7 x 10(3) and 0.2 x 10(3) per mm3, respectively. The typical atherogenic lipid profile was worse in older patients. A total of 69% of patients had low diffusion capacity for carbon monoxide, and more than one third had low forced expiratory volume in 1 second, forced vital capacity, and forced expiratory volume in 1 second/forced vital capacity at initial visit. All measurements of pulmonary function showed a gradual deterioration over time. Liver dysfunction was characterized by stable elevation of hepatic transaminases and bilirubin. Homozygotes for DeltaR608, P323A, and P330R had milder disease than patients with all other genotypes.
Conclusions: The natural history of NPD-B is characterized by hepatosplenomegaly with progressive hypersplenism, worsening atherogenic lipid profile, gradual deterioration in pulmonary function, and stable liver dysfunction.
Similar articles
-
Growth restriction in children with type B Niemann-Pick disease.J Pediatr. 2003 Apr;142(4):424-8. doi: 10.1067/mpd.2003.113. J Pediatr. 2003. PMID: 12712061
-
Acid sphingomyelinase deficiency: prevalence and characterization of an intermediate phenotype of Niemann-Pick disease.J Pediatr. 2006 Oct;149(4):554-9. doi: 10.1016/j.jpeds.2006.06.034. J Pediatr. 2006. PMID: 17011332
-
Acid sphingomyelinase (Asm) deficiency patients in The Netherlands and Belgium: disease spectrum and natural course in attenuated patients.Mol Genet Metab. 2012 Nov;107(3):526-33. doi: 10.1016/j.ymgme.2012.06.015. Epub 2012 Jun 30. Mol Genet Metab. 2012. PMID: 22818240
-
Sea-blue histiocytosis in a family with Niemann-Pick disease. A clinical, morphological and biochemical study.Sangre (Barc). 1992 Feb;37(1):59-67. Sangre (Barc). 1992. PMID: 1585241 Review.
-
Pulmonary involvement in Niemann-Pick disease: case report and literature review.Respir Med. 2000 Dec;94(12):1241-51. doi: 10.1053/rmed.2000.0942. Respir Med. 2000. PMID: 11192962 Review.
Cited by
-
The Liver and Lysosomal Storage Diseases: From Pathophysiology to Clinical Presentation, Diagnostics, and Treatment.Diagnostics (Basel). 2024 Jun 19;14(12):1299. doi: 10.3390/diagnostics14121299. Diagnostics (Basel). 2024. PMID: 38928715 Free PMC article. Review.
-
Niemann-Pick disease type B: HRCT assessment of pulmonary involvement.J Bras Pneumol. 2017 Nov-Dec;43(6):451-455. doi: 10.1590/S1806-37562017000000062. J Bras Pneumol. 2017. PMID: 29340494 Free PMC article.
-
Genetic Insights and Diagnostic Challenges in Highly Attenuated Lysosomal Storage Disorders.Genes (Basel). 2025 Jul 30;16(8):915. doi: 10.3390/genes16080915. Genes (Basel). 2025. PMID: 40869962 Free PMC article. Review.
-
Desensitization of olipudase alfa-induced anaphylaxis in a child with chronic neurovisceral acid sphingomyelinase deficiency.Mol Genet Metab Rep. 2024 Jul 17;40:101120. doi: 10.1016/j.ymgmr.2024.101120. eCollection 2024 Sep. Mol Genet Metab Rep. 2024. PMID: 39081552 Free PMC article.
-
Limitations of enzyme replacement therapy: current and future.J Inherit Metab Dis. 2006 Apr-Jun;29(2-3):442-7. doi: 10.1007/s10545-006-0239-6. J Inherit Metab Dis. 2006. PMID: 16763916
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical